Trial Profile
The effectiveness of converting to sirolimus versus continuation of a tacrolimus-based immunosupression regimen in low-risk recipients of a first kidney transplant.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary) ; Mycophenolate sodium; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 26 Jul 2012 New trial record
- 19 Jul 2012 Results presented at the 24th International Congress of the Transplantation Society.